Table of Contents
What changed
Revenue, which is disclosed as interest income, fell 50.9% to NZ$25.3m from NZ$51.5m in FY20 — consistent with a lower-rate environment on a large cash balance rather than any operating activity. The headline loss narrowed 26.4% to NZ$117.6m (PBT and NPAT identical; no tax in either year). Operating cash outflow improved to NZ$123.6m from NZ$159.9m, and the cash balance fell NZ$123.6m to NZ$2.1b. Total assets declined 5.5% to NZ$2.2b and equity 5.4% to NZ$2.1b, essentially tracking the full-year loss. No dividend was declared.
What matters
- The business is, for now, a cash-holding vehicle. Revenue is interest income and the 50.9% revenue fall reflects the yield on NZ$2.1b of cash, not operational performance. The loss of NZ$117.6m against NZ$25.3m of interest income implies roughly NZ$143m of costs/outflows being absorbed by the cash base each year.
- Cash is being consumed at a material absolute rate. Operating cash outflow of NZ$123.6m is ~5.8% of opening cash. The improvement from FY20 (-NZ$159.9m) is real but the trajectory still depletes optionality if no acquisition closes.
- Stated strategy remains "seeking acquisition targets." No target company, deal size, return hurdle or timeline has been disclosed, so the read on strategy progress is unchanged year on year.
Expectations
No formal financial targets, forward-work book, or quantitative guidance were provided. Seasonality is not particularly meaningful for an interest-bearing cash vehicle, but the HY21/FY21 split is informative: HY21 carried 72.1% of FY21 revenue and only 50.3% of the full-year loss, implying H2 revenue of just NZ$7.0m and H2 loss of NZ$58.5m. The H2 revenue step-down points to a further yield compression through the year; the loss run-rate was broadly stable half-on-half. Absent disclosed targets, the release supports neither a re-rating case nor a deterioration case — it supports only the status quo of a cash pile slowly shrinking while management searches for deployment.
Quality of result
The narrower loss is mechanically driven by the smaller gap between interest income and fixed operating costs of the vehicle; it is not evidence of operating improvement. With no EBITDA, capex, working-capital, or borrowings disclosure in the extraction, conventional quality tests cannot be applied. What can be said: NPAT (-NZ$117.6m) and operating cash outflow (-NZ$123.6m) are closely aligned, so there is no obvious accrual/cash divergence masking the result. The balance-sheet move (equity down NZ$117.6m, cash down NZ$123.6m, assets down NZ$125.3m) is internally consistent with the reported loss. The result is therefore durable in the sense that it is not timing-assisted — but it is also structurally dependent on prevailing interest rates on the cash balance.
Unresolved
- What is the composition of the NZ$143m-ish annual cost line that turns NZ$25.3m of interest income into a NZ$117.6m loss? The release excerpts do not break this out.
- What is the status, size, and timing of the acquisition targets referenced? No pipeline, mandate, or hurdle rate has been quantified.
- What yield is currently being earned on the NZ$2.1b cash balance, and how sensitive is revenue to further rate moves?
- Is any portion of the cash restricted, committed, or earmarked, and on what terms is it held?
- Are there any contingent liabilities or off-balance-sheet obligations behind the NZ$83.4m of total liabilities?
This briefing cannot assess the economic substance of the vehicle, the identity or viability of acquisition targets, or whether the cash balance is fully available for redeployment, because those details are not in the supplied extraction.
Key metrics
| Metric | FY21 | FY20 | Change |
|---|---|---|---|
| Revenue | $25.3m | $51.5m | -50.9% ↓ |
| Net profit after tax | −$117.6m | −$159.9m | +26.4% ↑ |
| Net cash inflow from operating activities | −$123.6m | −$159.9m | +22.7% ↑ |
| Profit before tax | −$117.6m | −$159.9m | +26.4% ↑ |
| Total assets | $2.2b | $2.3b | -5.5% ↓ |
Analytical metrics
| Metric | FY21 | FY20 | Context |
|---|---|---|---|
| ROE (annualised) | -5.7% | -7.3% | Strengthening |
| HY21 share of FY21 revenue | 72.1% | — | Other half was 27.9% |
| HY21 share of FY21 NPAT | 50.3% | — | Other half was 49.7% |
| Profit from continuing operations | −$117.6m | −$159.9m | +$42.3m |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.
Source-backed analysis from the filing set attached to this briefing.